RÉSUMÉ
The Tityus trinitatis, a black scorpion species endemic to the fauna of Trinidad, has been implicated in envenomation with devastating clinical sequelae such as acute pancreatitis and major adverse cardiovascular events. We present the first in-Caribbean case of a 59-year-old Caribbean South Asian male with human immunodeficiency virus who presented with a non-ST-segment-elevation acute coronary syndrome after being stung, which was managed with comprehensive, guideline-directed medical therapy. The clinician should be cognizant of scorpion-induced acute coronary syndrome (ACS) as a potential sequela of envenomation and its clinical management.
Sujet(s)
Syndrome coronarien aigu , Piqûres de scorpions , Humains , Mâle , Syndrome coronarien aigu/induit chimiquement , Syndrome coronarien aigu/étiologie , Adulte d'âge moyen , Piqûres de scorpions/complications , Piqûres de scorpions/traitement médicamenteux , Animaux , Électrocardiographie , Scorpions , Trinité-et-TobagoRÉSUMÉ
We report three cases of coronary artery aneurysm (CAA) in adults who presented with acute coronary syndrome. Two of these patients did not have traditional coronary artery disease risk factors. Management of CAA poses a significant challenge to interventionalists. We discuss the etiologic mechanisms, risk factors, pathophysiology, and diagnosis using angiography, intravascular ultrasound, and coronary computed tomography. We also highlight management options, including medical therapy and catheter-based interventions such as stenting, coil embolization, stent-assisted coil embolization, and surgical exclusion.
Sujet(s)
Syndrome coronarien aigu , Anévrysme coronarien , Coronarographie , Humains , Anévrysme coronarien/imagerie diagnostique , Anévrysme coronarien/thérapie , Syndrome coronarien aigu/thérapie , Syndrome coronarien aigu/imagerie diagnostique , Syndrome coronarien aigu/étiologie , Mâle , Résultat thérapeutique , Adulte d'âge moyen , Embolisation thérapeutique , Échographie interventionnelle , Femelle , Sujet âgé , Valeur prédictive des tests , Endoprothèses , Intervention coronarienne percutanée/instrumentation , Angiographie par tomodensitométrie , Facteurs de risqueRÉSUMÉ
Short-term exposure to air pollutants may contribute to an increased risk of acute coronary syndrome (ACS). This study assessed the role of short-term exposure to fine particulate matter (PM2.5) as well as fine and coarse PM (PM10) air pollution in ACS events and the effect of blood groups on this phenomenon. A retrospectively collected database of 9026 patients was evaluated. The study design was a case-crossover using a conditional logistic regression model. The main analysis focused on PM2.5 levels with a 1 day lag until the ACS event, using threshold-modelled predictor for all patients. Secondary analyses utilized separate threshold-modelled predictors for 2-7-days moving averages and for patients from specific ABO blood groups. Additional analysis was performed with the non-threshold models and for PM10 levels. Short-term exposure to increased PM2.5 and PM10 levels at a 1-day lag was associated with elevated risks of ACS (PM2.5: OR = 1.012 per + 10 µg/m3, 95% CI 1.003, 1.021; PM10: OR = 1.014 per + 10 µg/m3, CI 1.002, 1.025) for all patients. Analysis showed that exposure to PM2.5 was associated with increased risk of ACS at a 1-day lag for the A, B or AB group (OR = 1.012 per + 10 µg/m3, CI 1.001, 1.024), but not O group (OR = 1.011 per + 10 µg/m3, CI 0.994, 1.029). Additional analysis showed positive associations between exposure to PM10 and risk of ACS, with 7-days moving average models stratified by blood group revealing that exposures to PM2.5 and PM10 were associated with elevated risk of ACS for patients with group O. Short-term exposures to PM2.5 and PM10 were associated with elevated risk of ACS. Short-term exposure to PM2.5 was positively associated with the risk of ACS for patients with A, B, or AB blood groups for a 1-day lag, while risk in O group was delayed to 7 days.
Sujet(s)
Syndrome coronarien aigu , Pollution de l'air , Études croisées , Matière particulaire , Humains , Syndrome coronarien aigu/sang , Syndrome coronarien aigu/étiologie , Syndrome coronarien aigu/épidémiologie , Mâle , Femelle , Matière particulaire/effets indésirables , Pollution de l'air/effets indésirables , Adulte d'âge moyen , Sujet âgé , Études rétrospectives , Polluants atmosphériques/effets indésirables , Système ABO de groupes sanguins , Exposition environnementale/effets indésirables , Facteurs de risqueRÉSUMÉ
BACKGROUND: While it has been hypothesized that high plaque stress and strain may be related to plaque rupture, its direct verification using in vivo coronary plaque rupture data and full 3-dimensional fluid-structure interaction models is lacking in the current literature due to difficulty in obtaining in vivo plaque rupture imaging data from patients with acute coronary syndrome. This case-control study aims to use high-resolution optical coherence tomography-verified in vivo plaque rupture data and 3-dimensional fluid-structure interaction models to seek direct evidence for the high plaque stress/strain hypothesis. METHODS: In vivo coronary plaque optical coherence tomography data (5 ruptured plaques, 5 no-rupture plaques) were acquired from patients using a protocol approved by the local institutional review board with informed consent obtained. The ruptured caps were reconstructed to their prerupture morphology using neighboring plaque cap and vessel geometries. Optical coherence tomography-based 3-dimensional fluid-structure interaction models were constructed to obtain plaque stress, strain, and flow shear stress data for comparative analysis. The rank-sum test in the nonparametric test was used for statistical analysis. RESULTS: Our results showed that the average maximum cap stress and strain values of ruptured plaques were 142% (457.70 versus 189.22 kPa; P=0.0278) and 48% (0.2267 versus 0.1527 kPa; P=0.0476) higher than that for no-rupture plaques, respectively. The mean values of maximum flow shear stresses for ruptured and no-rupture plaques were 145.02 dyn/cm2 and 81.92 dyn/cm2 (P=0.1111), respectively. However, the flow shear stress difference was not statistically significant. CONCLUSIONS: This preliminary case-control study showed that the ruptured plaque group had higher mean maximum stress and strain values. Due to our small study size, larger scale studies are needed to further validate our findings.
Sujet(s)
Maladie des artères coronaires , Vaisseaux coronaires , Plaque d'athérosclérose , Contrainte mécanique , Tomographie par cohérence optique , Humains , Vaisseaux coronaires/imagerie diagnostique , Vaisseaux coronaires/physiopathologie , Vaisseaux coronaires/anatomopathologie , Rupture spontanée , Études cas-témoins , Maladie des artères coronaires/imagerie diagnostique , Maladie des artères coronaires/physiopathologie , Mâle , Femelle , Adulte d'âge moyen , Modèles cardiovasculaires , Sujet âgé , Valeur prédictive des tests , Syndrome coronarien aigu/imagerie diagnostique , Syndrome coronarien aigu/physiopathologie , Syndrome coronarien aigu/étiologieRÉSUMÉ
BACKGROUND: Acute coronary syndrome due to coronary artery embolism in the setting of ascending aortic thrombus is an uncommon condition, even rarer when there is no aortic pathology such as aneurysm, severe atherosclerosis, aortic dissection, or thrombophilia (whether inherited or acquired). CASE PRESENTATION: We report a case of a 58-year-old male presented with acute chest pain, electrocardiogram showing non-ST-elevation acute coronary syndrome. The computed tomography angiography of coronary artery revealed a mural thrombus in the proximal part of ascending aorta, located above the left coronary artery ostium, without any aortic pathologies. With the exception of hypertension and cigarette smoking, no other risk factors were identified in this patient that may increase the risk of thrombosis. Given the life-threatening risk of interventional therapy and surgery, the patient determinedly opted for anticoagulant and dual antiplatelet therapy. Then he experienced the reoccurrence of chest pain after 6-day treatment, progressed to anterior and inferior ST-segment elevation myocardial infarction. Coronary artery embolism originating from the ascending aortic thrombus was suspected. Considering the hemodynamic instability of the patient, the medical treatment was continued and bridged to warfarin and aspirin after discharge. Follow-up computed tomography angiography at 6 months showed no obstruction in coronary artery and complete resolution of the thrombus. No thromboembolic events occurred henceforward. CONCLUSIONS: Acute coronary syndrome could be a manifestation of secondary coronary embolism due to ascending aortic thrombus. Currently, there is no standardized guideline for the treatment of aortic mural thrombus, individualized treatment is recommended. When surgical therapy is not applicable for the patient, anticoagulation and dual antiplatelet treatment are alternative treatments that may successfully lead to the resolution of the aortic thrombus.
Sujet(s)
Syndrome coronarien aigu , Maladies de l'aorte , Récidive , Humains , Mâle , Adulte d'âge moyen , Syndrome coronarien aigu/étiologie , Syndrome coronarien aigu/diagnostic , Syndrome coronarien aigu/thérapie , Syndrome coronarien aigu/imagerie diagnostique , Résultat thérapeutique , Maladies de l'aorte/imagerie diagnostique , Maladies de l'aorte/étiologie , Maladies de l'aorte/complications , Thrombose/imagerie diagnostique , Thrombose/étiologie , Thrombose/traitement médicamenteux , Anticoagulants/usage thérapeutique , Angiographie par tomodensitométrie , Coronarographie , Antiagrégants plaquettaires/usage thérapeutique , Infarctus du myocarde sans sus-décalage du segment ST/imagerie diagnostique , Infarctus du myocarde sans sus-décalage du segment ST/thérapie , Infarctus du myocarde sans sus-décalage du segment ST/étiologie , AortographieSujet(s)
Syndrome coronarien aigu , Sténose coronarienne , Revascularisation myocardique , Intervention coronarienne percutanée , Infarctus du myocarde avec sus-décalage du segment ST , Humains , Syndrome coronarien aigu/imagerie diagnostique , Syndrome coronarien aigu/étiologie , Syndrome coronarien aigu/physiopathologie , Syndrome coronarien aigu/thérapie , Revascularisation myocardique/méthodes , Intervention coronarienne percutanée/méthodes , Guides de bonnes pratiques cliniques comme sujet , Essais contrôlés randomisés comme sujet , Fraction du flux de réserve coronaire , Coronarographie , Infarctus du myocarde avec sus-décalage du segment ST/imagerie diagnostique , Infarctus du myocarde avec sus-décalage du segment ST/étiologie , Infarctus du myocarde avec sus-décalage du segment ST/physiopathologie , Infarctus du myocarde avec sus-décalage du segment ST/thérapie , Sténose coronarienne/complications , Sténose coronarienne/imagerie diagnostique , Sténose coronarienne/physiopathologie , Sténose coronarienne/thérapieRÉSUMÉ
Takotsubo syndrome (TTS) is an acute reversible form of myocardial dysfunction, often preceded by a physical or emotional stressful event, that acts as a trigger. Despite, recent advances in the comprehension of the mechanisms leading to TTS, its pathophysiology is far from being completely understood. However, several studies seem to suggest that an acute coronary microvascular dysfunction may represent a crucial pathogenic mechanism involved in TTS occurrence. In this article, we aim to review the complex pathophysiology of TTS and the possible different mechanisms underlying this clinical condition, focusing on the role of coronary microvascular dysfunction and the remaining knowledge's gaps in the field.
Sujet(s)
Syndrome coronarien aigu , Syndrome de tako-tsubo , Syndrome de tako-tsubo/physiopathologie , Syndrome de tako-tsubo/étiologie , Syndrome de tako-tsubo/diagnostic , Humains , Syndrome coronarien aigu/physiopathologie , Syndrome coronarien aigu/étiologie , Animaux , Circulation coronarienne , MicrocirculationRÉSUMÉ
One of the complications during an acute coronary syndrome event is the presence of arrhythmias. Among them, those of the supraventricular type, especially atrial fibrillation, carry a poor prognosis both in the short and long term, being the cause of situations such as cerebrovascular event, ventricular arrhythmias, and increased mortality. The arrhythmia tends to appear in a certain population group with particular risk factors during the index event in approximately 10% of cases. Appropriate treatment at the time of its onset, thanks to the use of drugs that modulate heart rate, rhythm, and anticoagulant management in the most vulnerable groups, will lead to a less bleak outcome for these patients.
Una de las complicaciones durante un evento de síndrome coronario agudo es la presencia de arritmias. Dentro de ellas, las de tipo supraventricular, en especial fibrilación auricular, acarrea un mal pronóstico tanto a corto como a largo plazo y es la causa de situaciones como evento vascular cerebral, arritmias ventriculares y aumento de la mortalidad. Dicha arritmia tiende a aparecer en cierto grupo de población con particulares factores de riesgo durante el evento índice en aproximadamente 10% de los casos. Un tratamiento apropiado en el momento de su aparición, gracias al uso de fármacos que modulan la frecuencia cardiaca, el ritmo y el manejo anticoagulante en los grupos más vulnerables conllevará un desenlace menos sombrío para estos pacientes.
Sujet(s)
Syndrome coronarien aigu , Fibrillation auriculaire , Syndrome coronarien aigu/complications , Syndrome coronarien aigu/physiopathologie , Syndrome coronarien aigu/étiologie , Humains , Fibrillation auriculaire/complications , Fibrillation auriculaire/étiologie , Facteurs de risqueRÉSUMÉ
Coronary artery disease is presently one of the leading causes of death among cancer survivors. Due to the number of cancer survivors projected to reach 26 million by 2040 managing coronary disease in this population presents a unique challenge. Cancer patients face an elevated risk of atherosclerotic disease due to shared cardiovascular risk factors and the cardiotoxic effects of cancer therapies, predisposing them to acute coronary syndromes. Challenges in treating cancer patients presenting with acute coronary syndromes include atypical presentations, obscured symptoms, and the impact of cancer-related processes on traditional biomarkers. This review explores the complexities of acute coronary syndrome management in cancer patients, addressing challenges involved, recent advances in percutaneous strategies, pharmacology, and considerations for these high-risk individuals. This review discusses a balance between invasive vs. medical strategy, technical advances in multimodal imaging, intravascular physiology, intracoronary imaging, and evolving stent options, highlighting the need for tailored approaches in this complex patient population.
Sujet(s)
Syndrome coronarien aigu , Tumeurs , Humains , Syndrome coronarien aigu/thérapie , Syndrome coronarien aigu/étiologie , Tumeurs/complications , Mâle , FemelleRÉSUMÉ
Coronary sinus (CS) anomalies, although infrequent, are increasingly diagnosed with advances in interventional procedures and imaging techniques. Most cases are asymptomatic and incidentally diagnosed. We present a case of an elderly male without comorbidities who presented with acute angina. Coronary catheterisation revealed a double-vessel disease, but incidentally, sequential angiograms captured contrast filling in the levophase of CS, revealing a giant CS. Primary percutaneous angioplasty of the right coronary artery was performed successfully. Echocardiography confirmed the aneurysm, and a CT scan showed an aneurysmally dilated CS and other coronary veins alongside a normal-sized persistent left superior vena cava draining to the right atrium through CS. CS aneurysms may lead to complications such as thrombosis, embolic events, arrhythmias and heart failure, stressing the importance of vigilant monitoring and timely intervention. This case underscores the significance of recognising CS anomalies in cardiac procedures, even when asymptomatic, for proper management.
Sujet(s)
Syndrome coronarien aigu , Sinus coronaire , Humains , Mâle , Sujet âgé , Veine cave supérieure/imagerie diagnostique , Sinus coronaire/imagerie diagnostique , Sinus coronaire/malformations , Résultats fortuits , Syndrome coronarien aigu/imagerie diagnostique , Syndrome coronarien aigu/étiologie , ÉchocardiographieRÉSUMÉ
BACKGROUND: There are conflicting data on the risk of acute coronary syndrome (ACS) in patients with inflammatory bowel disease (IBD). Only a few previous reports include patients diagnosed during the last decade. AIM: To assess and compare the risk of ACS between patients with IBD and the general population. METHODS: In this cohort study, we used nationwide registers to identify patients diagnosed with IBD in Sweden 2003-2021. Every patient was matched by birth year, sex, calendar year and area of residence with up to 10 general population comparators. The primary outcome was incident ACS. We used semi-parametric Cox proportional hazard models to estimate hazard ratios (HRs). RESULTS: We identified 76,517 patients with IBD (Crohn's disease [CD], N = 22,732; ulcerative colitis [UC], N = 42,194 and IBD-unclassified, N = 11,591) and 757,141 comparators. During a median follow-up of 8 years, 2546 patients with IBD (37.5/10,000 person-years) were diagnosed with ACS compared with 19,598 (28.0/10,000 person-years) among comparators (HR 1.30; 95% confidence interval 1.24-1.35) after adjustments for confounding factors, and approximately one extra case of ACS in 100 IBD patients followed for 10 years. The highest HRs for ACS were in patients with elderly onset IBD (≥60 years) and among patients with CD or UC with extra-intestinal manifestations. No increased HRs were observed in patients diagnosed with IBD before the age of 40. CONCLUSION: In this contemporary cohort of patients with IBD, exposed to modern IBD care, there was an increased risk for ACS compared with individuals from the general population.
Sujet(s)
Syndrome coronarien aigu , Rectocolite hémorragique , Maladie de Crohn , Maladies inflammatoires intestinales , Humains , Sujet âgé , Études de cohortes , Suède/épidémiologie , Syndrome coronarien aigu/épidémiologie , Syndrome coronarien aigu/étiologie , Maladies inflammatoires intestinales/complications , Maladies inflammatoires intestinales/épidémiologie , Maladie de Crohn/épidémiologie , Rectocolite hémorragique/complications , Rectocolite hémorragique/épidémiologie , Rectocolite hémorragique/diagnostic , IncidenceSujet(s)
Syndrome coronarien aigu , Coronarographie , Vaisseaux coronaires , Plaque d'athérosclérose , Humains , Syndrome coronarien aigu/imagerie diagnostique , Syndrome coronarien aigu/étiologie , Syndrome coronarien aigu/thérapie , Dilatation pathologique , Vaisseaux coronaires/imagerie diagnostique , Vaisseaux coronaires/anatomopathologie , Mâle , Tomographie par cohérence optique , Adulte d'âge moyen , Résultat thérapeutique , Maladie des artères coronaires/imagerie diagnostique , Maladie des artères coronaires/complications , Maladie des artères coronaires/thérapieRÉSUMÉ
Background and Objectives: Acute coronary syndrome (ACS), a prevalent global cardiovascular disease and leading cause of mortality, is significantly correlated with meteorological factors. This study aims to analyze the impact of short-term changes in meteorological factors on the risk of ACS, both with and without ST-segment elevation, and to identify vulnerable subgroups. Materials and Methods: Daily ACS admissions and meteorological variables were collected from October 2016 to December 2021. A generalized linear model (GLM) with a Poisson distribution was employed to examine how short-term fluctuations in meteorological parameters influence ACS hospitalizations. Subgroup analyses were conducted to identify the populations most vulnerable to climate change. Results: Multiple regression analyses showed that short-term fluctuations in atmospheric pressure (≥10 mbar) and air temperature (≥5 °C) seven days prior increased the number of ACS hospitalizations by 58.7% (RR: 1.587; 95% CI: 1.501-1.679) and 55.2% (RR: 1.552; 95% CI: 1.465-1.644), respectively, notably impacting ST-segment elevation myocardial infarctions (STEMIs). The least pronounced association was observed between the daily count of ACS and the variation in relative air humidity (≥20%), resulting in an 18.4% (RR: 1.184; 95% CI: 1.091-1.286) increase in the risk of hospitalization. Subgroup analysis revealed an increased susceptibility among men and older adults to short-term variations in weather parameters. Conclusions: The findings indicate that short-term changes in weather conditions are associated with an increased risk of ACS hospitalizations, particularly STEMIs. Male and older adult patients exhibit heightened susceptibility to variations in climatic factors. Developing effective preventive strategies is imperative to alleviate the adverse consequences of these environmental risk factors.
Sujet(s)
Syndrome coronarien aigu , Infarctus du myocarde avec sus-décalage du segment ST , Humains , Mâle , Sujet âgé , Syndrome coronarien aigu/épidémiologie , Syndrome coronarien aigu/étiologie , Temps (météorologie) , Hospitalisation , Infarctus du myocarde avec sus-décalage du segment ST/étiologie , Infarctus du myocarde avec sus-décalage du segment ST/complications , TempératureRÉSUMÉ
Cardiovascular conditions in the spectrum of acute coronary syndromes are characterized by sex differences with regard to pathophysiology, risk factors, clinical presentation, invasive and pharmacologic treatment, and outcomes. This review delves into these differences, including specific subsets like myocardial infarction with non-obstructed coronary arteries or Spontaneous Coronary Artery Dissection, and alternative diagnoses like Takotsubo cardiomyopathy or myocarditis. Moreover, practical considerations are enclosed, on how a sex-specific approach should be integrated in clinical practice: in fact, personal history should focus on female-specific risk factors, and hormonal status and hormonal therapy should be assessed. Moreover, physical and psychological stressors should be investigated, particularly in the event of Spontaneous Coronary Artery Dissection or Takotsubo cardiomyopathy.
Sujet(s)
Syndrome coronarien aigu , Anomalies congénitales des vaisseaux coronaires , Infarctus du myocarde , Syndrome de tako-tsubo , Maladies vasculaires/congénital , Humains , Femelle , Mâle , Syndrome coronarien aigu/diagnostic , Syndrome coronarien aigu/épidémiologie , Syndrome coronarien aigu/étiologie , Syndrome de tako-tsubo/diagnostic , Syndrome de tako-tsubo/épidémiologie , Syndrome de tako-tsubo/étiologie , Caractères sexuels , Coronarographie/effets indésirables , Infarctus du myocarde/diagnostic , Facteurs de risque , Vaisseaux coronairesRÉSUMÉ
Red blood cell (RBC) transfusion therapy is often performed in patients with acute heart failure (AHF) and anemia; however, its impact on subsequent cardiovascular events is unclear. We examined whether RBC transfusion influences major adverse cardiovascular events (MACE) after discharge in patients with AHF and anemia.We classified patients with AHF and anemia (nadir hemoglobin level < 10 g/dL) according to whether they received RBC transfusion during hospitalization. The endpoint was MACE (composite of all-cause death, non-fatal acute coronary syndrome/stroke, or heart failure readmission) 180 days after discharge. For survival analysis, we used propensity score matching analysis with the log-rank test. As sensitivity analysis, we performed inverse probability weighting analysis and multivariable Cox regression analysis.Among 448 patients with AHF and anemia (median age, 81 years; male, 55%), 155 received RBC transfusion and 293 did not. The transfused patients had worse clinical features than the non-transfused patients, with lower levels of nadir hemoglobin and serum albumin and a lower estimated glomerular filtration rate. In the propensity-matched cohort of 87 pairs, there was no significant difference in the MACE-free survival rate between the 2 groups (transfused, 73.8% vs. non-transfused, 65.3%; P = 0.317). This result was consistent in the inverse probability weighting analysis (transfused, 76.0% vs. non-transfused, 68.7%; P = 0.512), and RBC transfusion was not significantly associated with post-discharge MACE in the multivariable Cox regression analysis (adjusted hazard ratio: 1.468, 95% confidence interval: 0.976-2.207; P = 0.065).In conclusion, this study suggests that RBC transfusions for anemia may not improve clinical outcomes in patients with AHF.
Sujet(s)
Syndrome coronarien aigu , Anémie , Défaillance cardiaque , Humains , Mâle , Sujet âgé de 80 ans ou plus , Transfusion d'érythrocytes/effets indésirables , Post-cure , Sortie du patient , Anémie/complications , Anémie/thérapie , Hémoglobines/analyse , Syndrome coronarien aigu/étiologie , Défaillance cardiaque/complications , Défaillance cardiaque/thérapieRÉSUMÉ
The objective of this study was to evaluate the predictive value of the Geriatric Nutritional Risk Index (GNRI) combined with the Systemic Immunoinflammatory Index (SII) for the risk of major adverse cardiovascular events (MACE) following percutaneous coronary intervention in elderly patients with acute coronary syndrome (ACS). We retrospectively reviewed the medical records of 1202 elderly patients with acute coronary syndromes divided into MACE and non-MACE groups according to whether they had a MACE. The sensitivity analysis utilized advanced machine learning algorithms to preliminarily identify the critical role of GNRI versus SII in predicting MACE risk. We conducted a detailed analysis using a restricted cubic spline approach to investigate the nonlinear relationship between GNRI, SII, and MACE risk further. We constructed a clinical prediction model based on three key factors: GNRI, SII, and Age. To validate the accuracy and usefulness of this model, we compared it to the widely used GRACE score using subject work and recall curves. Additionally, we compared the predictive value of models and GRACE scores in assessing the risk of MACE using the Integrated Discriminant Improvement Index (IDI) and the Net Reclassification Index (NRI). This study included 827 patients. The GNRI scores were lower in the MACE group than in the non-MACE group, while the SII scores were higher in the MACE group (P < 0.001). The multifactorial analysis revealed a low GNRI (OR = 2.863, 95% CI: 2.026-4.047, P = 0.001), High SII (OR = 3.102, 95% CI: 2.213-4.348, P = 0.001). The area under the curve (AUC) for the predictive model was 0.778 (95% CI: 0.744-0.813, P = 0.001), while the AUC for the GRACE score was 0.744 (95% CI: 0.708-0.779, P = 0.001). NRI was calculated to be 0.5569, with NRI + at 0.1860 and NRI- at 0.3708. The IDI was found to be 0.0571, with a P-value of less than 0.001. These results suggest that the newly developed prediction model is more suitable for use with the population in this study than the GRACE score. The model constructed using GNRI and SII demonstrated good standardization and clinical impact, as evidenced by the standard, DCA, and clinical impact curves. The study shows that combining GNRI and SII can be a simple, cost-effective, and valuable way to predict the risk of MACE within one year in elderly acute coronary syndromes.
Sujet(s)
Syndrome coronarien aigu , Intervention coronarienne percutanée , Humains , Sujet âgé , Syndrome coronarien aigu/diagnostic , Syndrome coronarien aigu/étiologie , Pronostic , Études rétrospectives , Modèles statistiques , Intervention coronarienne percutanée/effets indésirables , Appréciation des risquesSujet(s)
Syndrome coronarien aigu , Anomalies congénitales des vaisseaux coronaires , Pont myocardique , Infarctus du myocarde , Humains , Syndrome coronarien aigu/imagerie diagnostique , Syndrome coronarien aigu/étiologie , Syndrome coronarien aigu/thérapie , Résultat thérapeutique , Infarctus du myocarde/étiologie , Anomalies congénitales des vaisseaux coronaires/complications , Coronarographie/effets indésirablesRÉSUMÉ
BACKGROUND: The effect of different dual antiplatelet therapies on thrombotic events on the background of intravascular ultrasound (IVUS) guidance is unclear. We investigated whether ticagrelor can provide any additional benefit to clopidogrel in reducing thrombotic events in acute coronary syndrome (ACS) treated with drug- eluting stent (DES), when guided by IVUS or not. METHODS: A total of 5,666 ACS patients who underwent DES implantation and who were discharged on dual antiplatelet therapy were enrolled and grouped according to the use of IVUS or not. Each group was subdivided into two subgroups according to the type of P2Y12 inhibitor used after discharge. Propensity score matching (PSM) was used between the IVUS and no-IVUS groups. Covariate adjustment of Cox proportional hazards model was used between the ticagrelor and clopidogrel groups. Thrombotic event at 12 months was compared in groups separately. RESULTS: After PSM, 12-month follow-up data were available for 1,174 patients. Major adverse cardiac events (MACE) were less frequent in the IVUS-guided group (2.2% vs. 4.3%, P = 0.081) with a trend toward statistical significance. Comparison of antiplatelet regimens revealed significantly fewer major adverse cardiac and cerebrovascular events (MACCE) with ticagrelor in the entire PSM cohort and angiography-guided subgroup (2.9% vs. 5.7%, P = 0.035; 3.1% vs. 6.4%, P = 0.020, respectively). Among patients in the IVUS-guided group the outcome was comparable (2.5% vs. 4.4%, P = 0.312). Ticagrelor was associated with increasing bleeding incidence in the entire PSM cohort (1.3% vs. 3.3%, P = 0.030), mainly due to Bleeding Academic Research Consortium type 2 bleeding (0.7% vs. 2.6%, P = 0.010). The results were consistent after covariate adjustment of Cox proportional hazards model. CONCLUSION: The comparison of ischemic benefit between ticagrelor and clopidogrel was similar in patients receiving IVUS guidance during stent implantation, probably due to the precise implantation of IVUS. Multicenter, randomized studies should be performed to validate this conclusion.
Sujet(s)
Syndrome coronarien aigu , Endoprothèses à élution de substances , Intervention coronarienne percutanée , Thrombose , Humains , Syndrome coronarien aigu/imagerie diagnostique , Syndrome coronarien aigu/thérapie , Syndrome coronarien aigu/étiologie , Clopidogrel/effets indésirables , Coronarographie/effets indésirables , Endoprothèses à élution de substances/effets indésirables , Intervention coronarienne percutanée/effets indésirables , Intervention coronarienne percutanée/méthodes , Antiagrégants plaquettaires/effets indésirables , Score de propension , Thrombose/étiologie , Ticagrélor/effets indésirables , Résultat thérapeutique , Échographie interventionnelle/effets indésirablesRÉSUMÉ
OBJECTIVE: This study aims to assess the predictive value of the Systemic Immune Inflammation Index (SII) in determining in-stent restenosis (ISR) likelihood in patients with acute coronary syndrome (ACS) who have undergone percutaneous coronary intervention (PCI). METHODS: The study enrolled 903 ACS patients undergoing PCI, categorized into ISR (+) and ISR (-) groups based on control coronary angiography results. Demographic, clinical, laboratory, and angiographic-procedural characteristics were systematically compared. RESULTS: The ISR (+) group encompassed 264 individuals (29.2%), while the ISR (-) group comprised 639 individuals (70.8%). Patients had a mean age of 55.8â ±â 10.2 years, with 69% being male. The ISR (+) group had higher diabetes and smoking prevalence and notably larger stent dimensions. Lab parameters showed significantly elevated creatinine, total cholesterol, red cell distribution width, white blood cell and neutrophil counts, SII index and C-reactive protein (CRP) in the ISR (+) group, while lymphocyte levels were lower. Binary logistic regression identified stent diameter (odds ratio [OR]: 0.598, 95% confidence interval [CI]: 0.383-0.935; P â =â 0.024), stent length (OR: 1.166, 95% CI: 1.132-1.200; P â <â 0.001), creatinine (OR: 0.366, 95% CI: 0.166-0.771; P â =â 0.003), CRP (OR: 1.075, 95% CI: 1.042-1.110; P â =â 0.031), and SII index (OR: 1.014, 95% CI: 1.001-1.023; P â <â 0.001) as independent ISR predictors. CONCLUSION: The SII index exhibits potential as a predictive marker for ISR in ACS patients post-PCI, indicating systemic inflammation and heightened restenosis risk. Integrating the SII index into risk models could identify high-risk patients for targeted interventions.